Wealth Creation with 14-18 High Conviction Value Research based stock ideas
Skin in the Game
We invest in most of the stocks we share reports on and are SEBI Registered Analyst INH100001690
Forbes and ET Recognized
Featured in Economic Times and Forbes India's 2015 edition of Wealth Wizards
29% + XIRR
Strong Outperformance over NIFTY and SENSEX over the last 9 years
Premium Members Served
Internal Rate of Return (XIRR)
Years of Investing Experience
Years of Katalyst Wealth
Founder, Katalyst Wealth
Coming from a family of Stock investors, Ekansh started investing in stocks at a very young age and founded Katalyst Wealth in 2011.
He got featured in Forbes India's 2015 edition of Wealth Wizards and Economic Times (ET) May 2017 edition of Dons of Dalal Street.
He is supported by an in-house Operations team.
Aarti Drugs - 524%
Can Fin Homes - 977%
Orient Refractories - 578%
Cera Sanitaryware - 1,075%
14-18 easy to understand reports on stocks that have the potential to grow multi-fold (multibagger) with the avg. holding period of 2-4 years.
Special Situation Opportunities (SSOs)
Reports on opportunities arising out of corporate actions like delisting, demerger, buyback, etc with avg. holding period of 3-5 months.
An excel sheet on simulation of Portfolio performance on the basis of stock reports shared with members.
Access to all our active Investment Reports and Special situation opportunity reports, new or old
Latest updates with actionable insights on our recommendations to know where they stand and where they're headed next.
Not everyone grows up learning about markets, stock investing; but, if you want to learn more, you will get plenty of lessons from us
14- 18 Investment Reports
Past Reports (including closed)
14-18 Investment Reports
5-6 Special Situation Reports
Past Reports (including closed)
[2011-2020]: Year Wise Stock Research Performance
Dear Sir, We are glad to share with you the Comprehensive Performance of Katalyst Wealth (KW) since its inception. KW stock research was started in 2011 and we have completed 1 full bull-bear cycle of the markets. From 2011-13, the markets were down in the dumps, then we had a great 2014-17 and now again the markets are down and starting to recover. A full cycle is long enough and encapsulates both the good and the bad and therefore the
Special Situation: Hexaware Technologies Delisting...Closed with 24% + gain
Dear Readers, We keep saying that besides long-term investment, one should also look at Special situation opportunities like delistings, buybacks, demergers, etc because in a lot of such cases the correlation with the markets is much lower and therefore such opportunities add stability to the portfolio and deliver additional gains. In line with the same philosophy, we would like to share with you details on Hexaware Technologies Delisting opportunity. We shared the same with Alpha + members. Hexaware Technologies delisting opportunity was shared with
[Stock Idea] Chaman Lal Setia - Can it again multiply Investor's wealth?
Dear Sir, Hope you are doing well. With this mail, we would like to share with you an interesting stock idea: Chaman Lal Setia Exports (BSE: 530307). While the name of the company may not be very inspiring, they are actually doing very good business in the Basmati rice exports segment. Despite the pandemic and the lockdown, for Q1 the company has reported ~18% growth in sales and more than 200% growth in profits on YOY basis. For us as
Aarti Drugs - 500% + Return in the last few months...Is it time to be Cautious?
Dear Sir, Hope you are doing well. It’s always to great to have stocks that end up multiplying your wealth several times; however, during one’s holding of such stocks there also comes a time when one needs to get cautious and have some profit protection strategy in place. Here, we are talking about Aarti Drugs. The stock has been a great wealth creator for our Premium Members as we could identify the stock at levels of 550 in Sep’18 and since
Model Portfolio that has beaten almost all the Large, Mid and Small Cap Funds
Dear Members, Hope you all are doing well. We have completed 2 years of Model Sheet service and would like to share with you our Performance card. The Model Sheet service was started on 15th Aug’18 and the purpose of the same was 2-fold: Determine performance of our stock research on Portfolio basis (against benchmark indices) than on individual stocks basis Give an easily replicable (from any point onwards) sheet to members so that they can make the most of
[Report]: Delisting Opportunity - Low Downside and Expecting Promoters to buy out at much higher price
Dear Sir, Hope you are doing good and taking proper precautions. As you might be aware, besides investing in stocks of good companies for long term wealth creation, another smarter way of making money in stock markets is to participate in Special situation opportunities (SSOs). Have also benefited from this strategy with several Special Situation opportunities like Ineos Styrosolution delisting, Suven life-Suven Pharma demerger, Linde India delisting, Hexaware delisting, etc appreciating by 20-140% in a period of 2-11 months. SSOs are relatively shorter term (3-4 months) opportunities and
Katalyst Wealth's stock research has been consistently accurate over the years. Their approach is conservative but still regularly find out quality stock-picks at mouth-watering valuations. They put the client's interests first.
Subscriber, Abu Dhabi and Author of "A Safari in the Equity World"
Your service is exceptionally good, stock picks are excellent and well-researched and most importantly you guys are transparent and frank when some stock misfires. Looking forward to many years of Symbiotic relationship.
Ekansh does wonderful research. His ideas have good growth potential with balanced risk. I have been a subscriber for last 3 years and have learnt a lot from his write-ups.
Subscriber, Lucknow and Co-Founder 'Screener.in'
I sincerely thank you for your genuine research on stocks such as Suven Lifesciences, Manappuram Finance and many more. They have helped me not only grow my money but also my confidence to invest in stock market.
Subscriber, New Delhi
I have been your client for more than 7 years now. Your services and research are simply excellent and my capital has appreciated greatly. Thanks for the same.
I trust your sincerity and dedication. The value you bring through your research is much more than what you charge. It's really good I found you. I feel safe even in negative market environment.
Subscriber, Newcastle, Australia
Monday - Friday
10am - 5pm
7, Panch Ratan, 7/128
Swaroop Nagar, Kanpur - 208002
WHO WE ARE
www.katalystwealth.com (herein referred to as 'Katalyst Wealth') is the domain owned by Mittal Consulting. We offer Independent Equity research services to investors on subscription basis. SEBI (Research Analyst) Registration No. INH100001690
Copyright ©2020 Mittal Consulting. All rights reserved.